EW
34
-2
DUK
57
3
ORLY
62
4
HES
47
2
RRC
65
3
HCA
55
-4
CSX
37
3
ABBV
66
2
CF
53
-3
ADI
76
3
GRMN
61
2
BWA
42
5
ROST
46
-3
COP
44
7
PEP
35
5
NAVI
32
-3
PM
75
-2
BA
43
-2
NRG
69
-6
CCI
33
3
EW
34
-2
DUK
57
3
ORLY
62
4
HES
47
2
RRC
65
3
HCA
55
-4
CSX
37
3
ABBV
66
2
CF
53
-3
ADI
76
3
GRMN
61
2
BWA
42
5
ROST
46
-3
COP
44
7
PEP
35
5
NAVI
32
-3
PM
75
-2
BA
43
-2
NRG
69
-6
CCI
33
3
Financhill
Back

Sage Therapeutics Stock Predictions

Sleep well at night with 7 stellar stocks to buy and hold forever

Get the complete list FREE for a limited time.
Sell
36

SAGE
Sage Therapeutics

Last Price:
$6.77
Seasonality Move:
-6.91%

7 Day Trial

ALL ACCESS PASS

$ 7

7 Stocks to Buy and Hold Forever

The result is a select group of high-quality blue-chip stocks.

Sage Therapeutics Stock Forecast

  • Over the next 52 weeks, Sage Therapeutics has on average historically risen by 8.7% based on the past 10 years of stock performance.
  • Sage Therapeutics has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Sage Therapeutics Stock Undervalued?
    The current Sage Therapeutics [SAGE] share price is $6.99. The Score for SAGE is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SAGE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Sage Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Sage Therapeutics has on average historically risen by 8.7% based on the past 10 years of stock performance.

Sage Therapeutics Stock Rating

Sell
36
Sage Therapeutics (SAGE) is a Sell

Is Sage Therapeutics overpriced?

  • Sage Therapeutics has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Sage Therapeutics Stock Price History

Is SAGE stock going to rise?

  • The current trend is relatively stagnant and SAGE is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagerx.com

52-Week Data

52-Week High:
13.47
52-Week Low:
4.62

Prediction Charts

Market Cap:
437.7M
Price in USD:
6.99
Volume:
876.3K
Beta:
1.25

Technical Analysis

SMA50:
7.04
SMA100:
7.26
SMA200:
6.93
52-Wk Change:
-35.87%

Stock Predictions

  • Is Sage Therapeutics stock public?
    Yes, Sage Therapeutics is a publicly traded company.
  • What is the Sage Therapeutics stock quote today?
    The Sage Therapeutics stock price is 6.99 USD today.
  • How to buy Sage Therapeutics stock online?
    You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-21 7.12 6.80 7.14 6.78
May-22 6.81 6.61 6.82 6.59
May-23 6.54 6.53 6.60 6.50
May-27 6.60 6.52 6.78 6.49
May-28 6.52 6.48 6.60 6.46
May-29 6.50 6.52 6.60 6.46
May-30 6.46 6.46 6.53 6.35
Jun-2 6.46 6.62 6.68 6.39
Jun-3 6.63 6.53 6.73 6.49
Jun-4 6.53 6.54 6.67 6.51
Jun-5 6.53 6.78 6.96 6.50
Jun-6 6.82 6.85 6.90 6.61
Jun-9 6.95 6.81 6.95 6.72
Jun-10 6.86 6.99 7.11 6.80

Sage Therapeutics Earnings

Sage Therapeutics Earnings Report: Per Share Sage Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Sage Therapeutics Forecast Revenue Growth

Sage Therapeutics Stock Analysis: Historical quarterly revenues per share for Sage Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.42 per share, an increase this year of $2.76 per share, and an increase next year of $0.46 per share.

* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.